Market research
MTLS Materialise NV
NASDAQ USD Technology
Latest close
As of 30 Oct 2026
Test a moving-average rule with historical data.
Market facts
- Market cap
- 461M
- P/E ratio
- 28.57
- Analyst target
- 8.8251
- Dividend yield
- Not available
- Beta
- 1.33
Profile
Instrument facts
- Exchange
- NASDAQ
- Currency
- USD
- Sector
- Technology
- Industry
- Software - Application
- ISIN
- Not available
- Market cap
- 461M
- P/E ratio
- 28.57
- Analyst target
- 8.8251
- Dividend yield
- Not available
- Beta
- 1.33
About
About Materialise NV
Materialise NV provides additive manufacturing and medical software tools, and 3D printing services in the Americas, Europe, Africa, and the Asia-Pacific. The company operates through three segments: Materialise Software, Materialise Medical, and Materialise Manufacturing. The Materialise Software segment offers proprietary software through programs and platforms that enable and enhance the functionality of 3D printers, and printing operations. Its software interfaces between various types of 3D printers; and various software applications and capturing technologies, including computer-aided design/computer-aided manufacturing packages and 3D scanners; a MES, software providers. This segment serves 3D printing machine manufacturers; production companies and contract manufacturers in automotive, aerospace, consumer goods, and hearing aid industries; and 3D printing service bureaus through its sales force, website, and third-party distributors. The Materialise Medical segment provides medical software that allows medical-image based analysis, planning, and engineering, as well as patient-specific design and printing of surgical devices and implants. It serves medical device companies, hospitals, universities, research institutes, and industrial companies. The Materialise Manufacturing segment provides 3D printing services, design and engineering services, and rapid prototyping and additive manufacturing of production parts to customers serving the automotive, consumer goods industrial goods, semiconductor, art and architecture and aerospace markets. The company has collaboration agreements with Zimmer Biomet Holdings, Inc.; Encore Medical, L.P.; DePuy Synthes Companies of Johnson & Johnson; Limacorporate Spa; Mathys AG; Smith & Nephew Inc.; Corin Ltd; Medtronic Inc.; and Abbott Laboratories Inc. Materialise NV was incorporated in 1990 and is headquartered in Leuven, Belgium.
Research context
Materialise NV appears in PyInvesting’s US Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- USD
- Sector
- Technology
- Industry
- Software - Application
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
1 comment
Sign in to join the MTLS discussion.
5 years, 7 months ago
Materialise NV is currently in a long term downtrend where the price is trading 45.0% below its 200 day moving average.
From a valuation standpoint, the stock is 62.0% cheaper than other stocks from the Technology sector with a price to sales ratio of 9.6.
Materialise NV's total revenue sank by 10.7% to $45M since the same quarter in the previous year.
Its net income has dropped by 261.5% to $-2M since the same quarter in the previous year.
Finally, its free cash flow grew by 503.0% to $12M since the same quarter in the previous year.
Based on the above factors, Materialise NV gets an overall score of 2/5.